Upadacitinib for Refractory Paediatric Atopic Dermatitis: A Real-World Study on Effectiveness and Safety in Dupilumab Nonresponders.
Mu-Tong ZhaoYi ZhuangYuan LiangLin MaChunping ShenPublished in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2024)